Advertisement

Pediatric Surgery International

, Volume 30, Issue 8, pp 853–859 | Cite as

The impact of Clostridium difficile on paediatric surgical practice: a systematic review

  • D. Mc Laughlin
  • F. Friedmacher
  • P. Puri
Original Article

Abstract

Purpose

The pathogenic potential of Clostridium difficile in children remains a controversial subject as healthy infants can be colonised by this organism. However recent analyses have clarified that C. difficile is an important enteropath in paediatric populations, particularly in antibiotic-associated diarrhoea. Paediatric surgical patients including those with Hirschsprung’s disease (HD) may be especially vulnerable to C. difficile infection (CDI) and complicated C. difficile enterocolitis such as pseudomembranous colitis may require surgical management if refractory to medical therapy. Reports of increasing prevalence and emergence of hyper-virulent strains of C. difficile worldwide prompted an examination of the literature to assess the impact of CDI on current paediatric surgical practise.

Methods

The literature was searched using a combination of the MESH terms “hirschsprung’s disease”, “enterocolitis”, “clostridium difficile”, and “children”. Cases of Hirschsprung’s associated enterocolitis (HAEC) investigated for C. difficile and complicated CDI in non HD patients were identified and analysed for clinical parameters, diagnostic evaluations, surgical interventions and outcome.

Results

Pathogen isolation in HAEC was infrequently described. Only 98 children have been reported with C. difficile during an episode of HAEC over the last 40 years and aetiology remains unclear as asymptomatic carriage of C. difficile in HD occurs. Nonetheless 34 confirmed cases of pseudomembranous colitis complicating HD are reported in the literature with an associated 50 % mortality rate. Over 20 % of non Hirschsprung’s patients with reported severe or complicated CDI required operative intervention. The need for surgery was associated with the presence of co-morbidity and high mortality occurred in this group.

Conclusion

Severe or complicated CDI in both HD and non HD paediatric patients is associated with high mortality and often requires surgical intervention. Although these patient cohorts represent a small number of cases, CDI should be suspected in children presenting with enterocolitis to enable early diagnosis and timely surgical intervention, particularly in patients with co-morbid conditions or preceding antibiotic use.

Keywords

Hirschsprung’s disease Enterocolitis Clostridium difficile Pseudomembranous colitis Children 

References

  1. 1.
    Karas JA, Enoch DA, Aliyu SH (2010) A review of mortality due to Clostridium difficile infection. J Infect 61(1):1–8PubMedGoogle Scholar
  2. 2.
    Pant C, Deshpande A, Altaf MA, Minocha A, Sferra TJ (2013) Clostridium difficile infection in children: a comprehensive review. Curr Med Res Opin 29(8):967–984PubMedGoogle Scholar
  3. 3.
    Larson HE, Price AB, Honour P, Borriello SP (1978) Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1(8073):1063–1066PubMedGoogle Scholar
  4. 4.
    George RH, Symonds JM, Dimock F, Brown JD, Arabi Y, Shinagawa N, Keighley MR, Alexander-Williams J, Burdon DW (1978) Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1(6114):695PubMedCentralPubMedGoogle Scholar
  5. 5.
    Bhangu A, Nepogodiev D, Gupta A, Torrance A, Singh P (2012) Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis. Br J Surg 99(11):1501–1513PubMedGoogle Scholar
  6. 6.
    Noblett SE, Welfare M, Seymour K (2009) The role of surgery in Clostridium difficile colitis. BMJ 338:b1563PubMedGoogle Scholar
  7. 7.
    Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T (2008) Epidemiological features of Clostridium difficile-associated disease among inpatients at children’s hospitals in the United States, 2001–2006. Pediatrics 122(6):1266–1270PubMedGoogle Scholar
  8. 8.
    Zilberberg MD, Tillotson GS, McDonald C (2010) Clostridium difficile infections among hospitalized children, United States, 1997–2006. Emerg Infect Dis 16(4):604–609PubMedCentralPubMedGoogle Scholar
  9. 9.
    Lee J, Tashjian DB, Moriarty KP (2012) Is partial colectomy the operation of choice in pediatric Clostridium difficile colitis? Pediatr Surg Int 28(6):603–607PubMedGoogle Scholar
  10. 10.
    Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB (2011) Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 165(5):451–457PubMedGoogle Scholar
  11. 11.
    Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353(23):2442–2449PubMedGoogle Scholar
  12. 12.
    Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491):1079–1084PubMedGoogle Scholar
  13. 13.
    Thomas DF, Fernie DS, Bayston R, Spitz L, Nixon HH (1986) Enterocolitis in Hirschsprung’s disease: a controlled study of the etiologic role of Clostridium difficile. J Pediatr Surg 21(1):22–25PubMedGoogle Scholar
  14. 14.
    Murphy F, Puri P (2005) New insights into the pathogenesis of Hirschsprung’s associated enterocolitis. Pediatr Surg Int 21(10):773–779PubMedGoogle Scholar
  15. 15.
    Frykman PK, Short SS (2012) Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg 21(4):328–335PubMedCentralPubMedGoogle Scholar
  16. 16.
    Wilson-Storey D, Scobie WG, McGenity KG (1990) Microbiological studies of the enterocolitis of Hirschsprung’s disease. Arch Dis Child 65(12):1338–1339PubMedCentralPubMedGoogle Scholar
  17. 17.
    Hardy SP, Bayston R, Spitz L (1993) Prolonged carriage of Clostridium difficile in Hirschsprung’s disease. Arch Dis Child 69(2):221–224PubMedCentralPubMedGoogle Scholar
  18. 18.
    Libby JM, Donta ST, Wilkins TD (1983) Clostridium difficile toxin A in infants. J Infect Dis 148(3):606PubMedGoogle Scholar
  19. 19.
    Zwiener RJ, Belknap WM, Quan R (1989) Severe pseudomembranous enterocolitis in a child: case report and literature review. Pediatr Infect Dis J 8(12):876–882PubMedGoogle Scholar
  20. 20.
    Adler SP, Chandrika T, Berman WF (1981) Clostridium difficile associated with pseudomembraneous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child 135(9):820–822PubMedGoogle Scholar
  21. 21.
    Auritt WA, Hervada AR, Fendrick G (1978) Fatal pseudomembranous enterocolitis following oral ampicillin therapy. J Pediatr 93(5):882–883PubMedGoogle Scholar
  22. 22.
    Christie DL, Ament ME (1975) Ampicillin-associated colitis. J Pediatr 87(4):657–658PubMedGoogle Scholar
  23. 23.
    Hyams JS, Berman MM, Helgason H (1981) Nonantibiotic-associated enterocolitis caused by Clostridium difficile in an infant. J Pediatr 99(5):750–752PubMedGoogle Scholar
  24. 24.
    Keating JP, Frank AL, Barton LL, Tedesco FJ (1974) Pseudomembranous colitis associated with ampicillin therapy. Am J Dis Child 128(3):369–370PubMedGoogle Scholar
  25. 25.
    Lazar HL, Wesley JR, Weintraub WH, Coran AG (1978) Pseudomembranous colitis associated with antibiotic therapy in a child: report of a case and review of the literature. J Pediatr Surg 13(6):488–491PubMedGoogle Scholar
  26. 26.
    Schussheim A, Goldstein EJC (1980) Antibiotic-associated pseudomembranous colitis in siblings. Pediatrics 66(6):932–935PubMedGoogle Scholar
  27. 27.
    Sinatra F, Buntain WL, Mitchell CH, Sunshine P (1976) Cholestyramine treatment of pseudomembranous colitis. J Pediatr 88(2):304–306PubMedGoogle Scholar
  28. 28.
    Kelber M, Ament ME (1976) Shigella dysenteriae I: a forgotten cause of pseudomembranous colitis. J Pediatr 89(4):595–596PubMedGoogle Scholar
  29. 29.
    Price EH, Borriello SP, Ward H, Brereton RJ, Risdon RA, Tabaqchali S (eds) (1990) Clostridium difficile and severe enterocolities in three infants. Clinical and molecular aspects of anerobes, vol 8073, 6th Biennial International Symposium edn. Wrightson Biomedical Publishing Ltd, PetersfieldGoogle Scholar
  30. 30.
    Genta VM, Gilligan PH, McCarthy LR (1984) Clostridium difficile peritonitis in a neonate. A case report. Arch Pathol Lab Med 108(1):82–83PubMedGoogle Scholar
  31. 31.
    Ware R, Friedman HS, Gutman LT, Rourk MH, Shorter NA, Filston HC (1988) Combined medical and surgical management of severe pseudomembranous colitis. Pediatr Infect Dis J 7(8):602–604PubMedGoogle Scholar
  32. 32.
    Azmy AA, Raine PA, Young DG (1990) Pseudomembranous enterocolitis–a potentially lethal disease. J Pediatr Surg 25(4):453–456PubMedGoogle Scholar
  33. 33.
    Scopes JW, Smith MF, Beach RC (1980) Pseudomembranous colitis and sudden infant death. Lancet 1(8178):1144PubMedGoogle Scholar
  34. 34.
    Angel CA, Green J, Swischuk L, Patel J (2004) Severe ciprofloxacin-associated pseudomembranous colitis in an 8-year-old child. J Pediatr Surg 39(10):1590–1592PubMedGoogle Scholar
  35. 35.
    Auletta JJ, John CC (2002) Community-acquired, non-antibiotic-associated Clostridium difficile colitis in a child. Infect Dis Clin Pract 11(7):397–398Google Scholar
  36. 36.
    Harmon T, Burkhart G, Applebaum H (1992) Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg 27(6):744–746PubMedGoogle Scholar
  37. 37.
    Babbit CJ, Romansky SG (2006) Clostridium difficile sepsis in a child with sickle cell disease. Infect Dis Clin Pract 14(2):112–113Google Scholar
  38. 38.
    Benson L, Song X, Campos J, Singh N (2007) Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 28(11):1233–1235PubMedGoogle Scholar
  39. 39.
    Boey CCM, Ramanujam TM, Looi LM (1997) Clostridium difficile-related necrotizing pseudomembranous enteritis in association with Henoch-Schonlein purpura. J Pediatr Gastroenterol Nutr 24(4):426–429PubMedGoogle Scholar
  40. 40.
    Perelman R, Rowe JC, Christie DL, Hodson WA (1981) Pseudomembranous colitis following obstruction in a neonate. Clin Pediatr 20(3):212–214Google Scholar
  41. 41.
    Singer DB, Cashore WJ, Widness JA, Campognone P, Hillemeier C (1986) Pseudomembranous colitis in a preterm neonate. J Pediatr Gastroenterol Nutr 5(2):318–320PubMedGoogle Scholar
  42. 42.
    Han VKM, Sayed H, Chance GW, Brabyn DG, Shaheed WA (1983) An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy? Pediatrics 71(6):935–941PubMedGoogle Scholar
  43. 43.
    Bustinza A, Solana MJ, Padilla B, Lopez-Herce J, Santiago MJ, Marin M (2009) Nosocomial outbreak of Clostridium difficile-associated disease in a pediatric intensive care unit in Madrid. Infect Control Hosp Epidemiol 30(2):199–201PubMedGoogle Scholar
  44. 44.
    Castillo A, Lopez J, Panadero E, Cerda J, Padilla B, Bustinza A (2012) Conservative surgical treatment for toxic megacolon due to Clostridium difficile infection in a transplanted pediatric patient. Transpl Infect Dis 14(4):E34–E37PubMedGoogle Scholar
  45. 45.
    Patel A, Gossett JJ, Benton T, Rowell E, Russell H, Cham E, Pahl E (2012) Fulminant Clostridium difficile toxic megacolon in a pediatric heart transplant recipient. Pediatr Transplant 16(1):E30–E34PubMedGoogle Scholar
  46. 46.
    Rakhit A, Nurko S, Gauvreau K, Mayer JE, Blume ED (2002) Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant 21(7):751–759PubMedGoogle Scholar
  47. 47.
    Rosen JB, Schecter MG, Heinle JS, McKenzie ED, Morales DL, Dishop MK, Danziger-Isakov L, Mallory GB, Elidemir O (2010) Clostridium difficile colitis in children following lung transplantation. Pediatr Transplant 14(5):651–656PubMedGoogle Scholar
  48. 48.
    Pokorn M, Radsel A, Cizman M, Jereb M, Karner P, Kalan G, Grosek S, Andlovic A, Rupnik M (2008) Severe Clostridium difficile-associated disease in children. Pediatr Infect Dis J 27(10):944–946PubMedGoogle Scholar
  49. 49.
    Morinville V, McDonald J (2005) Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 19(8):497–501PubMedGoogle Scholar
  50. 50.
    Viscidi RP, Bartlett JG (1981) Antibiotic-associated pseudomembranous colitis in children. Pediatrics 67(3):381–386PubMedGoogle Scholar
  51. 51.
    Davies J, Beck E (1981) Recurrent colitis following antibiotic-associated pseudomembranous colitis. Postgrad Med J 57(671):599–601PubMedCentralPubMedGoogle Scholar
  52. 52.
    Rivlin J, Lerner A, Augarten A, Wilschanski M, Kerem E, Ephros MA (1998) Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J Pediatr 132(1):177–179PubMedGoogle Scholar
  53. 53.
    Hussain SZ, Chu C, Greenberg DP, Orenstein D, Khan S (2004) Clostridium difficile colitis in children with cystic fibrosis. Dig Dis Sci 49(1):116–121PubMedGoogle Scholar
  54. 54.
    Qualman SJ, Petric M, Karmali MA, Smith CR, Hamilton SR (1990) Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. Am J Clin Pathol 94(4):410–416PubMedGoogle Scholar
  55. 55.
    Gryboski JD, Pellerano R, Young N, Edberg S (1991) Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol 86(6):685–689PubMedGoogle Scholar
  56. 56.
    Castagnola E, Battaglia T, Bandettini R, Caviglia I, Baldelli I, Nantron M, Moroni C, Garaventa A (2009) Clostridium difficile-associated disease in children with solid tumors. Support Care Cancer 17(3):321–324PubMedGoogle Scholar
  57. 57.
    Gogate A, De A, Nanivadekar R, Mathur M, Saraswathi K, Jog A, Kulkarni MV (2005) Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res 122(6):518–524PubMedGoogle Scholar
  58. 58.
    Kim J, Shaklee JF, Smathers S, Prasad P, Asti L, Zoltanski J, Dul M, Nerandzic M, Coffin SE, Toltzis P, Zaoutis T (2012) Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 31(2):134–138PubMedGoogle Scholar
  59. 59.
    Pai S, Aliyu SH, Enoch DA, Karas JA (2013) Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. PLoS One 7(12):e51728Google Scholar
  60. 60.
    Vora S, Glikman D, Kahanna M, Dawn RS (2006) Severe diarrhea and shock. Pediatr Infect Dis J 25 (3):279+ 284–285Google Scholar
  61. 61.
    Schwartz KL, Darwish I, Richardson SE, Mulvey MR, Thampi N (2014) Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study. BMC Pediatrics 14(1):28PubMedCentralPubMedGoogle Scholar
  62. 62.
    Durand CL, Miller PF (2009) Severe Clostridium difficile colitis and reactive arthritis in a 10-year-old child. Pediatr Infect Dis J 28(8):750–751PubMedGoogle Scholar
  63. 63.
    Rooney N, Variend S, Taitz LS (1988) Haemolytic uraemic syndrome and pseudomembranous colitis. Pediatr Nephrol 2(4):415–418PubMedGoogle Scholar
  64. 64.
    Schuller I, Saha V, Lin L, Kingston J, Eden T, Tabaqchali S (1995) Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 72(3):219–222PubMedCentralPubMedGoogle Scholar
  65. 65.
    Spivack JG, Eppes SC, Klein JD (2003) Clostridium difficile-associated diarrhea in a pediatric hospital. Clin Pediatr (Phila) 42(4):347–352Google Scholar
  66. 66.
    Schechter R, Peterson B, McGee J, Idowu O, Bradley J (1999) Clostridium difficile colitis associated with infant botulism: near-fatal case analogous to Hirschsprung’s enterocolitis. Clin Infect Dis 29(2):367–374PubMedGoogle Scholar
  67. 67.
    Batts DH, Martin D, Holmes R, Silva J, Fekety FR (1980) Treatment of antibiotic-associated Clostridium difficile diarrhea with oral vancomycin. J Pediatr 97(1):151–153PubMedGoogle Scholar
  68. 68.
    Donta ST, Stuppy MS, Myers MG (1981) Neonatal antibiotic-associated colitis. Am J Dis Child 135(2):181–182PubMedGoogle Scholar
  69. 69.
    Harrod MJE, Brown MS, Weinberg AG, Harkness WN, Goldstein JL (1975) Familial pseudomembranous colitis and its relation to lincomycin therapy. Am J Dig Dis 20(9):808–812PubMedGoogle Scholar
  70. 70.
    McReynolds EW, Foianini JE (1975) Pseudomembranous colitis secondary to penicillin and adrenocorticotropin abuse. J Tenn Med Assoc 68 (1):17–18 + 25Google Scholar
  71. 71.
    Simila S, Kouvalainen K, Makela P (1976) Pseudomembranous colitis after amoxycillin. Lancet 2(7980):317–318PubMedGoogle Scholar
  72. 72.
    Buts JP, Weber AM, Roy CC, Morin CL (1977) Pseudomembranous enterocolitis in childhood. Gastroenterology 73(4 I):823–827PubMedGoogle Scholar
  73. 73.
    Larson HE, Parry JV, Price AB, Davies DR, Dolby J, Tyrrell DA (1977) Undescribed toxin in pseudomembranous colitis. Br Med J 1(6071):1246–1248PubMedCentralPubMedGoogle Scholar
  74. 74.
    Prince AS, Neu HC (1979) Antibiotic-associated pseudomembranous colitis in children. Pediatr Clin North Am 26(2):261–268PubMedGoogle Scholar
  75. 75.
    Cashore WJ, Peter G, Lauermann M, Stonestreet BS, Oh W (1981) Clostridia colonization and clostridial toxin in neonatal necrotizing enterocolitis. J Pediatr 98(2):308–311PubMedGoogle Scholar
  76. 76.
    Brook I, Avery G, Glasgow A (1982) Clostridium difficile in paediatric infections. J Infect 4(3):253–257PubMedGoogle Scholar
  77. 77.
    Sherertz RJ, Sarubbi FA (1982) The prevalence of Clostridium difficile and toxin in a nursery population: a comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr 100(3):435–439PubMedGoogle Scholar
  78. 78.
    Holmes R, Byrne WJ (1986) Relapsing pseudomembranous colitis. J Pediatr Gastroenterol Nutr 5(2):314–315PubMedGoogle Scholar
  79. 79.
    Miholic J, Weninger M, Helmer F, Khoss A, Lessky E, Pollak A (1986) Antibiotic-associated pseudomembranous colitis as cause of intestinal obstruction in a 5-day-old newborn. Padiatr Padol 21(2):183–187PubMedGoogle Scholar
  80. 80.
    Burgner DP, Rfidah H, Beattie TJ, Seal DV (1993) Clostridium difficile after haemolytic uraemic syndrome. Arch Dis Child 69(2):239–240PubMedCentralPubMedGoogle Scholar
  81. 81.
    Bagwell CE, Langham MR Jr, Mahaffey SM, Talbert JL, Shandling B (1992) Pseudomembranous colitis following resection for Hirschsprung’s disease. J Pediatr Surg 27(10):1261–1264PubMedGoogle Scholar
  82. 82.
    Behbehani AW, Fischer G, Rahlf G (1983) Pseudomembranous colitis in Hirschsprung disease. Klin Padiatr 195(5):358–360PubMedGoogle Scholar
  83. 83.
    Brearly S, Armstrong GR, Nairn R, Gornall P, Currie ABM, Buick RG, Corkery JJ (1987) Pseudomembranous colitis: a lethal complication of Hirschsprung’s disease unrelated to antibiotic usage. J Pediatr Surg 22(3):257–259PubMedGoogle Scholar
  84. 84.
    Marty TL, Matlak ME, Hendrickson M, Black RE, Johnson DG (1995) Unexpected death from enterocolitis after surgery for Hirschsprung’s disease. Pediatrics 96(1 Pt 1):118–121PubMedGoogle Scholar
  85. 85.
    Parsons SJ, Fenton E, Dargaville P (2005) Clostridium difficile associated severe enterocolitis: a feature of Hirschsprung’s disease in a neonate presenting late. J Paediatr Child Health 41(12):689–690PubMedGoogle Scholar
  86. 86.
    Pini Prato A, Rossi V, Avanzini S, Mattioli G, Disma N, Jasonni V (2011) Hirschsprung’s disease: what about mortality? Pediatr Surg Int 27(5):473–478PubMedGoogle Scholar
  87. 87.
    Pozo F, Soler P, Ladron de Guevara C (1994) Pseudomembranous colitis associated with Hirschsprung’s disease. Clin Infect Dis 19(6):1160–1161PubMedGoogle Scholar
  88. 88.
    Suita S, Sakaguchi T, Arima T, Taguchi T, Yamanaka K (1994) Toxic megacolon in Hirschsprung’s disease is still potentially fatal. Pediatr Surg Int 9(5–6):433–435Google Scholar
  89. 89.
    Urushihara N, Kohno S, Hasegawa S (1994) Pseudomembranous enterocolitis and hemorrhagic necrotizing enterocolitis in Hirschsprung’s disease. Surg Today 24(3):221–224PubMedGoogle Scholar
  90. 90.
    Vieten D, Spicer R (2004) Enterocolitis complicating Hirschsprung’s disease. Semin Pediatr Surg 13(4):263–272PubMedGoogle Scholar
  91. 91.
    Carneiro PMR, Brereton RJ, Drake DP, Kiely EM, Spitz L, Turnock R (1992) Enterocolitis in Hirschsprung’s disease. Pediatr Surg Int 7(5):356–360Google Scholar
  92. 92.
    Ooi CY, Dilley AV, Day AS (2009) Saccharomyces boulardii in a child with recurrent Clostridium difficile. Pediatr Int 51(1):156–158PubMedGoogle Scholar
  93. 93.
    Singh R, Cameron BH, Walton JM, Farrokhyar F, Borenstein SH, Fitzgerald PG (2007) Postoperative Hirschsprung’s enterocolitis after minimally invasive Swenson’s procedure. J Pediatr Surg 42(5):885–889PubMedGoogle Scholar
  94. 94.
    Suita S, Taguchi T, Ieiri S, Nakatsuji T (2005) Hirschsprung’s disease in Japan: analysis of 3,852 patients based on a nationwide survey in 30 years. J Pediatr Surg 40(1):197–202PubMedGoogle Scholar
  95. 95.
    Teitelbaum DH, Caniano DA, Qualman SJ (1989) The pathophysiology of Hirschsprung’s-associated enterocolitis: importance of histologic correlates. J Pediatr Surg 24(12):1271–1277PubMedGoogle Scholar
  96. 96.
    Wilson-Storey D (1994) Microbial studies of enterocolitis in Hirschsprung’s disease. Pediatr Surg Int 9(4):248–250Google Scholar
  97. 97.
    Rangel SJ, Fung M, Graham DA, Ma L, Nelson CP, Sandora TJ (2011) Recent trends in the use of antibiotic prophylaxis in pediatric surgery. J Pediatr Surg 46(2):366–371PubMedGoogle Scholar
  98. 98.
    Schutze GE, Willoughby RE (2013) Clostridium difficile infection in infants and children. Pediatrics 131(1):196–200PubMedGoogle Scholar
  99. 99.
    Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG (2007) Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5(3):345–351PubMedGoogle Scholar
  100. 100.
    Pant C, Anderson MP, Deshpande A, Altaf MA, Grunow JE, Atreja A, Sferra TJ (2013) Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease. Inflamm Bowel Dis 19(5):1080–1085PubMedGoogle Scholar
  101. 101.
    Austin KM (2012) The pathogenesis of Hirschsprung’s disease-associated enterocolitis. Semin Pediatr Surg 21(4):319–327PubMedGoogle Scholar
  102. 102.
    Pastor AC, Osman F, Teitelbaum DH, Caty MG, Langer JC (2009) Development of a standardized definition for Hirschsprung’s-associated enterocolitis: a Delphi analysis. J Pediatr Surg 44(1):251–256PubMedGoogle Scholar
  103. 103.
    Sarioglu A, Cahit Tanyel F, Büyükpamukçu NH, Hiçsönmez A (1997) Clinical risk factors of hirschsprung—associated enterocolitis I: preoperative enterocolitis. Turk J Pediatr 39(1):81–89PubMedGoogle Scholar
  104. 104.
    Sarioglu A, Cahit Tanyel F, Büyükpamukçu NH, Hiçsönmez A (1997) Clinical risk factors of hirschsprung—associated enterocolitis II: postoperative enterocolitis. Turk J Pediatr 39(1):91–98PubMedGoogle Scholar
  105. 105.
    Surana R, Quinn FMJ, Puri P (1994) Evaluation of risk factors in the development of enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int 9(4):234–236Google Scholar
  106. 106.
    Wang JS, Lee HC, Huang FY, Chang PY, Sheu JC (2004) Unexpected mortality in pediatric patients with postoperative Hirschsprung’s disease. Pediatr Surg Int 20(7):525–528PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.National Children’s Research Centre, Our Lady’s Children’s HospitalDublin 12Ireland
  2. 2.Children’s University HospitalDublin 1Ireland

Personalised recommendations